A combination of an antioxidant with a prebiotic exerts greater efficacy than either as a monotherapy on cognitive improvement in castrated-obese male rats.

Metabolic Brain Disease
Titikorn ChunchaiSiriporn C Chattipakorn

Abstract

Previous studies by ourselves and others have demonstrated that both obesity and testosterone deprivation have been related to cognitive decline. We have also shown that a prebiotic and n-acetyl cysteine (NAC) improved cognitive dysfunction in obese rats and castrated-male rats. However, the effects of NAC, a prebiotic (inulin), and a combination of the two on cognition in castrated-obese rats has never been investigated. The hypothesis was that NAC and inulin attenuated cognitive decline in castrated-obese rats by improving gut dysbiosis, and decreasing oxidative stress, glial activation and apoptosis. Male Wistar rats (n = 36) were fed with either a normal diet (ND: n = 6) or a high-fat diet (HFD: n = 30) for twenty-eight weeks. The resultant obese rats had a bilateral orchiectomy (ORX) and were randomly divided into five subgroups (n = 6/ subgroup). Each subgroup was treated with one of five therapies: a vehicle; testosterone replacement (2 mg/kg/day); NAC (100 mg/kg); inulin (10%, w/w), or a combination of the NAC and inulin for four weeks. The results demonstrated that castrated-obese rats developed gut dysbiosis, metabolic disturbance, brain pathologies, and cognitive decline. All of the pathological conditions in the bra...Continue Reading

References

Sep 5, 2002·The Journal of Comparative Neurology·Daniel García-OvejeroLydia L Doncarlos
May 10, 2005·The British Journal of Nutrition·Michaël MessaoudiDidier Desor
Feb 21, 2006·Neuroscience·N J MacLuskyC Leranth
Jul 4, 2006·European Journal of Pharmacology·Yeda S DinizEthel L B Novelli
Apr 5, 2007·Nature Protocols·Charles V Vorhees, Michael T Williams
Apr 26, 2007·Diabetes·Patrice D CaniRémy Burcelin
Sep 3, 2009·Clinical & Experimental Ophthalmology·Gina Y TsaiJoanne A Matsubara
Nov 13, 2009·Journal of Neurophysiology·Kwan Yeop LeeJin Mo Chung
May 26, 2010·Clinics in Geriatric Medicine·Nazem Bassil, John E Morley
Jul 24, 2010·Antioxidants & Redox Signaling·Cynthia A Massaad, Eric Klann
Sep 25, 2010·Nature·Sebastian E WinterAndreas J Bäumler
Oct 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Vakkat Muraleedharan, T Hugh Jones
Jan 15, 2013·Neuron·Helmut KettenmannAlexei Verkhratsky
Nov 7, 2013·Nutritional Neuroscience·Linnea R FreemanAnn-Charlotte Granholm
Apr 24, 2014·Journal of Basic and Clinical Physiology and Pharmacology·Atish PrakashAnil Kumar
Dec 20, 2014·Endocrinology·Abdulmaged M TraishMohit Khera
Jun 2, 2015·Nature Neuroscience·Daniel ErnyMarco Prinz
Jun 24, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Mattias GüntherMårten Risling
Jul 29, 2015·Nature Reviews. Gastroenterology & Hepatology·John F Cryan, Timothy G Dinan
Dec 9, 2015·Proceedings of the National Academy of Sciences of the United States of America·Miriam E BocarslyElizabeth Gould
Mar 11, 2016·Food & Function·A FlorowskaE Dłużewska
Mar 16, 2016·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M M HurleyS Choi
Mar 24, 2016·The Journal of Endocrinology·Wanpitak PongkanNipon Chattipakorn
Apr 19, 2016·Chemico-biological Interactions·Michael CostaMaria E Pereira
May 11, 2016·Pharmaceutical Research·Yongjie MaDexi Liu
Jun 18, 2016·International Journal of Molecular Sciences·Cristina BuiguesOmar Cauli

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA
confocal microscopy
testosterone replacement therapy

Software Mentioned

SMART
Sholl
Imaris

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis